Wako, Japan

Konstanty Wierzba

This inventor holds 3 USPTO granted patents. Top assignee: Riken Corporation. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Konstanty Wierzba. Retrieved from https://idiyas.com/inventor/konstanty-wierzba-0c8oywq7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 33.3

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Konstanty Wierzba: Innovator in Anti-Malarial Research

Introduction

Konstanty Wierzba is a notable inventor based in Wako, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-malarial agents. With a total of 3 patents to his name, Wierzba is recognized for his innovative approaches to combating malaria.

Latest Patents

Wierzba's latest patents focus on the prevention and treatment of malaria using metal chelators as active ingredients. One of his inventions involves an anti-malarial drug that utilizes a metal chelator represented by specific chemical formulas, including tris(2-pyridylmethyl)amine. This innovative approach aims to enhance the efficacy of malaria treatment and prevention.

Career Highlights

Wierzba is currently associated with Riken Corporation, where he continues to advance his research in anti-malarial agents. His work has garnered attention for its potential impact on global health, particularly in regions where malaria is endemic.

Collaborations

Some of Wierzba's notable coworkers include Akira Wada and Hiroki Hayase. Their collaborative efforts contribute to the ongoing research and development of effective treatments for malaria.

Conclusion

Konstanty Wierzba's contributions to anti-malarial research highlight his commitment to addressing critical health challenges. His innovative patents and collaborations position him as a key figure in the fight against malaria.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…